Mitchell County Hospital Critical Access Hospital (Medicare Certified) Location: 90 Stephens Street, Camilla, Georgia 31730 Ratings:NA Phone: (229) 336-5284 |
News Archive
Agilent Technologies Inc. today announced its microarrays were used in a landmark research study on prenatal samples. The three-year study was designed to evaluate the accuracy, efficacy and potential advantages of using microarray analysis as compared with conventional karyotyping. Agilent SurePrint CGH microarrays and analysis software were used for the majority sample cohort of 4,400 samples.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
Diabetic retinopathy is one of the main vascular complications of type 2 diabetes, and the most common cause of visual deterioration in adults.
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.
› Verified 1 days ago